Greece Pharmaceuticals & Healthcare Report Q2 2013 - New Study Released
BMI View: The Greek pharmaceutical market will continue to be characterised by mandated price reductions, state intervention in the trade of pharmaceutical goods, regressive revenue taxes, unpaid debts and drug shortages. Moreover, the Greek government will continue to shift the burden of healthcare spending onto its citizens, requiring co-payments for expensive drugs and payments for outpatient visits.
View full press release